Seeing Beyond Pixels
For Better Diagnosis. For Better Drug Development.
Our partners depend on the information in bio- and medical images to advance scientific research, to shorten drug development timeline and to improve diagnostic accuracy for better patient care. They come to Keen Eye for tools to improve their productivity and outcome, and to uncover insights and meanings out of huge amounts of data. Learn more here about how Keen Eye’s team of data scientists create AI-powered applications to give them a competitive edge to get ahead.
Contract Research Organizations
Reduce costs and promote standardization
As a CRO providing services to pharma drug development, you need access to the latest technology to be competitive. Keen Eye’s cutting edge AI applications for image analysis deliver fast and reproducible biomarker quantification to improve your productivity and bottomline.
Pharma / Biotech Drug Development
Find insights in tissue images to accelerate drug development
Whether you want to confirm disease progression or to stratify patients, outsource your biomarker quantification and discovery projects to digital pathology machine learning experts at Keen Eye. We accompany you from research to clinical trials to help reduce your pipeline risks with our regulatory-ready applications.
Diagnostic & Healthcare Tech Companies
Offer AI solutions to grow your topline
You don’t need to start from scratch when you want to improve your products and services, or expand your reach to a wider market with new offerings using Artificial Intelligence. Tap into Keen Eye’s innovative deep learning engine and the team of data scientists to rapidly develop proprietary AI-powered solutions. Our licensing model takes the risk out of adopting new technology.